De novo-developed antibodies to donor MHC antigens lead to dysregulation of microRNAs and induction of MHC class II

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 6133-6143

  Xu, Zhongping ^a   Nayak, Deepak K ^a   Benshoff, Nicholas ^a   Hachem, Ramsey ^a   Gelman, Andrew E ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA BINDING PROTEIN; H 2 AA ANTIGEN; H 2 DMA ANTIGEN; HLA ANTIGEN CLASS 2; HLA DPA1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MICRORNA; MICRORNA 125B; MICRORNA 16; MICRORNA 195; MICRORNA 1966; MICRORNA 200C; MICRORNA 3069; MICRORNA 3470B; MICRORNA 467A 8; REGULATORY FACTOR X 5; UNCLASSIFIED DRUG; ALLOANTIBODY; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN; RFX5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BIOINFORMATICS; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; CHRONIC LUNG ALLOGRAFT REJECTION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUCIFERASE ASSAY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; CLUSTER ANALYSIS; DONOR; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GRAFT RECIPIENT; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; REPRODUCIBILITY; RNA INTERFERENCE;

ANIMALS; CLUSTER ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; ISOANTIBODIES; LUNG; LUNG TRANSPLANTATION; MICE; MICRORNAS; MODELS, ANIMAL; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, MESSENGER; TISSUE DONORS; TRANSCRIPTION FACTORS; TRANSPLANT RECIPIENTS;

EID: 84931330072     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401848     Document Type: Article

References (53)

1. Boehler, A., and M. Estenne. 2003. Post-transplant bronchiolitis obliterans. Eur. Respir. J. 22: 1007-1018.
2. Hachem, R. R., and E. P. Trulock. 2004. Bronchiolitis obliterans syndrome: pathogenesis and management. Semin. Thorac. Cardiovasc. Surg. 16: 350-355.
3. Sharples, L. D., K. McNeil, S. Stewart, and J. Wallwork. 2002. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J. Heart Lung Transplant. 21: 271-281.
4. Estenne, M., and M. I. Hertz. 2002. Bronchiolitis obliterans after human lung transplantation. Am. J. Respir. Crit. Care Med. 166: 440-444.
5. Smith, M. A., S. Sundaresan, T. Mohanakumar, E. P. Trulock, J. P. Lynch, D. L. Phelan, J. D. Cooper, and G. A. Patterson. 1998. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J. Thorac. Cardiovasc. Surg. 116: 812-820.
6. Tiriveedhi, V., J. Weber, A. Seetharam, and T. Mohanakumar. 2010. Cross-talk of alloimmune response and autoimmunity: role in pathogenesis of chronic rejection. Discov. Med. 9: 229-235.
7. Hachem, R. R. 2009. Lung allograft rejection: diagnosis and management. Curr. Opin. Organ Transplant. 14: 477-482.
8. Jaramillo, A., C. R. Smith, T. Maruyama, L. Zhang, G. A. Patterson, and T. Mohanakumar. 2003. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum. Immunol. 64: 521-529.
9. Jaramillo, A., M. A. Smith, D. Phelan, S. Sundaresan, E. Trulock, J. Lynch, J. Cooper, G. A. Patterson, and T. Mohanakumar. 1999. Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant. Proc. 31: 185-186.
10. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
11. Harris, A., S. M. Krams, and O. M. Martinez. 2010. MicroRNAs as immune regulators: implications for transplantation. Am. J. Transplant. 10: 713-719.
12. Sui, W., Y. Dai, Y. Huang, H. Lan, Q. Yan, and H. Huang. 2008. Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transpl. Immunol. 19: 81-85.
13. Anglicheau, D., V. K. Sharma, R. Ding, A. Hummel, C. Snopkowski, D. Dadhania, S. V. Seshan, and M. Suthanthiran. 2009. MicroRNA expression profiles predictive of human renal allograft status. Proc. Natl. Acad. Sci. USA 106: 5330-5335.
14. Xiao, C., D. P. Calado, G. Galler, T. H. Thai, H. C. Patterson, J. Wang, N. Rajewsky, T. P. Bender, and K. Rajewsky. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
15. Stittrich, A. B., C. Haftmann, E. Sgouroudis, A. A. Küuhl, A. N. Hegazy, I. Panse, R. Riedel, M. Flossdorf, J. Dong, F. Fuhrmann, et al. 2010. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 11: 1057-1062.
16. Fukami, N., S. Ramachandran, D. Saini, M. Walter, W. Chapman, G. A. Patterson, and T. Mohanakumar. 2009. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J. Immunol. 182: 309-318.
17. Colvin, J. S., B. Feldman, J. H. Nadeau, M. Goldfarb, and D. M. Ornitz. 1999. Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene. Dev. Dyn. 216: 72-88.
18. Chaudhuri, A. A., A. Y. So, N. Sinha, W. S. Gibson, K. D. Taganov, R. M. O'Connell, and D. Baltimore. 2011. MicroRNA-125b potentiates macrophage activation. J. Immunol. 187: 5062-5068.
19. Tili, E., J. J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru, B. Adair, M. Fabbri, H. Alder, C. G. Liu, G. A. Calin, and C. M. Croce. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179: 5082-5089.
20. Wendlandt, E. B., J. W. Graff, T. L. Gioannini, A. P. McCaffrey, and M. E. Wilson. 2012. The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation. Innate Immun 18: 846-855.
21. Williams, M. C., and L. G. Dobbs. 1990. Expression of cell-specific markers for alveolar epithelium in fetal rat lung. Am. J. Respir. Cell Mol. Biol. 2: 533-542.
22. Renella, R., C. Picard, B. Neven, M. Ouachée-Chardin, J. L. Casanova, F. Le Deist, M. Cavazzana-Calvo, S. Blanche, and A. Fischer. 2006. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections. Br. J. Haematol. 134: 510-516.
23. Chakraborty, M., D. Bhattacharya, C. Mukhopadhyay, and A. Chakrabarti. 2010. Structure and conformational studies on dityrosine formation in the DNA binding domain of RFX5. Biophys. Chem. 149: 92-101.
24. Clausen, B. E., J. M. Waldburger, F. Schwenk, E. Barras, B. Mach, K. Rajewsky, I. Förster, and W. Reith. 1998. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity 8: 143-155.
25. Sundaresan, S., T. Mohanakumar, M. A. Smith, E. P. Trulock, J. Lynch, D. Phelan, J. D. Cooper, and G. A. Patterson. 1998. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65: 648-653.
26. Jaramillo, A., F. G. Fernández, E. Y. Kuo, E. P. Trulock, G. A. Patterson, and T. Mohanakumar. 2005. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr. Transplant. 9: 84-93.
27. Saini, D., J. Weber, S. Ramachandran, D. Phelan, V. Tiriveedhi, M. Liu, N. Steward, A. Aloush, R. Hachem, E. Trulock, et al. 2011. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J. Heart Lung Transplant. 30: 624-631.
28. Takenaka, M., V. Tiriveedhi, V. Subramanian, K. Hoshinaga, A. G. Patterson, and T. Mohanakumar. 2012. Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease. PLoS ONE 7: e42370.
29. Haque, M. A., T. Mizobuchi, K. Yasufuku, T. Fujisawa, R. R. Brutkiewicz, Y. Zheng, K. Woods, G. N. Smith, O. W. Cummings, K. M. Heidler, et al. 2002. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol. 169: 1542-1549.
30. Harris, P. E., H. Bian, and E. F. Reed. 1997. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis. J. Immunol. 159: 5697-5704.
31. Poy, M. N., L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, P. E. Macdonald, S. Pfeffer, T. Tuschl, N. Rajewsky, P. Rorsman, and M. Stoffel. 2004. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
32. Wu, D., and A. K. Murashov. 2013. MicroRNA-431 regulates axon regeneration in mature sensory neurons by targeting the Wnt antagonist Kremen1. Front Mol Neurosci 6: 35.
33. Gotanda, K., T. Hirota, N. Matsumoto, and I. Ieiri. 2013. MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells. BMC Cancer 13: 369.
34. Liu, X., Z. Zhan, L. Xu, F. Ma, D. Li, Z. Guo, N. Li, and X. Cao. 2010. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα. J. Immunol. 185: 7244-7251.
35. Mycko, M. P., M. Cichalewska, A. Machlanska, H. Cwiklinska, M. Mariasiewicz, and K. W. Selmaj. 2012. MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc. Natl. Acad. Sci. USA 109: E1248-E1257.
36. Bottazzo, G. F., R. Pujol-Borrell, T. Hanafusa, and M. Feldmann. 1983. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2: 1115-1119.
37. He, J., C. Li, X. N. Yuan, J. L. Zhang, Y. Li, X. D. Wei, and J. Q. Hou. 2013. Anti-human leukocyte antigens and anti-major histocompatibility complex class I-related chain A antibody expression in kidney transplantation during a four-year follow-up. Chin. Med. J. (Engl.) 126: 2815-2820.
38. Ayala García, M. A., B. González Yebra, A. L. López Flores, and E. Guaní Guerra. 2012. The major histocompatibility complex in transplantation. J. Transplant. 2012: 842141.
39. Cox, S.T., H. A. Stephens, R. Fernando, A. Karasu, M. Harber, A. J. Howie, S. Powis, Y. Zou, P. Stastny, J. A. Madrigal, and A. M. Little. 2011. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum. Immunol. 72: 827-834.
40. Morales-Buenrostro, L. E., and J. Alberú. 2008. Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation. Transplant. Rev. (Orlando) 22: 27-38.
41. Bach, F. H. 1973. The major histocompatibility complex in transplantation immunology. Transplant. Proc. 5: 23-29.
42. Romaniuk, A., J. Prop, A. H. Petersen, C. R. Wildevuur, and P. Nieuwenhuis. 1987. Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts. Transplantation 44: 209-214.
43. Villard, J., M. Peretti, K. Masternak, E. Barras, G. Caretti, R. Mantovani, and W. Reith. 2000. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y. Mol. Cell. Biol. 20: 3364-3376.
44. Stavride, P., P. Arampatzi, and J. Papamatheakis. 2013. Differential regulation of MHCII genes by PRMT6, via an AT-hook motif of RFX5. Mol. Immunol. 56: 390-398.
45. Brickey, W. J., K. L. Wright, X. S. Zhu, and J. P. Ting. 1999. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor. J. Immunol. 163: 6622-6630.
46. DeSandro, A., U. M. Nagarajan, and J. M. Boss. 1999. The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am. J. Hum. Genet. 65: 279-286.
47. Peijnenburg, A., M. J. Van Eggermond, S. J. Gobin, R. Van den Berg, B. C. Godthelp, J. M. Vossen, and P. J. Van den Elsen. 1999. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5. J. Immunol. 163: 794-801.
48. Peijnenburg, A., M. C. Van Eggermond, R. Van den Berg, O. Sanal, J. M. Vossen, and P. J. Van den Elsen. 1999. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics 49: 338-345.
49. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9: 1021-1032.
50. Villard, J., W. Reith, E. Barras, A. Gos, M. A. Morris, S. E. Antonarakis, P. J. Van den Elsen, and B. Mach. 1997. Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency. Hum. Mutat. 10: 430-435.
51. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16: 1045-1055.
52. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20: 273-277.
53. Reith, W., S. Satola, C. H. Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53: 897-906.